Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim similar study in healthy participants
RBR-6wdrhwPhase 1Not yet recruiting
- Sponsor
- CAEP
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of pegfilgrastim in neutropenia (2 arms), sponsored by CAEP. Primary endpoint: Not reported. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on RBR-6wdrhw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6wdrhw.